Login / Signup

Anamorelin: Ghrelin Receptor Agonism as a Potential Intervention for Osteosarcopenia.

Palak PatadiaRobert V Considine
Published in: The Journal of clinical endocrinology and metabolism (2024)
Keyphrases
  • randomized controlled trial
  • human health
  • risk assessment
  • climate change
  • growth hormone